Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | HMX2 | Human | 1,1-dichloroethene | decreases expression | ISO | Hmx2 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of HMX2 mRNA | CTD | PMID:26682919 | HMX2 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of HMX2 mRNA | CTD | PMID:30723492 | HMX2 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of HMX2 mRNA | CTD | PMID:22574217 | HMX2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hmx2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HMX2 mRNA | CTD | PMID:24058054 | HMX2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMX2 mRNA | CTD | PMID:33387578 | HMX2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HMX2 mRNA | CTD | PMID:32109520 | HMX2 | Human | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of HMX2 mRNA | CTD | PMID:33476716 | HMX2 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Hmx2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of HMX2 mRNA | CTD | PMID:30951980 | HMX2 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of HMX2 gene | CTD | PMID:31601247 | HMX2 | Human | acrylamide | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of HMX2 mRNA | CTD | PMID:28959563 | HMX2 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of HMX2 promoter | CTD | PMID:23974009 | HMX2 | Human | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of HMX2 mRNA | CTD | PMID:26272509 | HMX2 | Human | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMX2 mRNA | CTD | PMID:27188386 | HMX2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of HMX2 exon | CTD | PMID:27901495 | HMX2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of HMX2 promoter | CTD | PMID:27901495 | HMX2 | Human | bis(2-chloroethyl) sulfide | increases expression | ISO | Hmx2 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of HMX2 mRNA | CTD | PMID:15674843 and PMID:15674844 | HMX2 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HMX2 mRNA | CTD | PMID:33476716 | HMX2 | Human | bisphenol A | affects methylation | ISO | Hmx2 (Mus musculus) | 6480464 | bisphenol A affects the methylation of HMX2 promoter | CTD | PMID:27334623 | HMX2 | Human | bisphenol A | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of HMX2 mRNA | CTD | PMID:25181051 | HMX2 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of HMX2 mRNA | CTD | PMID:33476716 | HMX2 | Human | C60 fullerene | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of HMX2 mRNA | CTD | PMID:19167457 | HMX2 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of HMX2 mRNA | CTD | PMID:25979313 | HMX2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | HMX2 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of HMX2 mRNA | CTD | PMID:26272509 | HMX2 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMX2 mRNA | CTD | PMID:27188386 | HMX2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of HMX2 gene | CTD | PMID:31601247 | HMX2 | Human | gentamycin | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of HMX2 mRNA | CTD | PMID:33387578 | HMX2 | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of HMX2 mRNA | CTD | PMID:24449571 | HMX2 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of HMX2 mRNA | CTD | PMID:36318118 | HMX2 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMX2 mRNA | CTD | PMID:27188386 | HMX2 | Human | paracetamol | decreases expression | ISO | Hmx2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of HMX2 mRNA | CTD | PMID:33387578 | HMX2 | Human | pirinixic acid | decreases expression | ISO | Hmx2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of HMX2 mRNA | CTD | PMID:20813756 | HMX2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | HMX2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of HMX2 mRNA | CTD | PMID:24516582 | HMX2 | Human | succimer | multiple interactions | ISO | Hmx2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMX2 mRNA | CTD | PMID:21641980 | HMX2 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of HMX2 mRNA | CTD | PMID:24935251 | HMX2 | Human | triptonide | increases expression | ISO | Hmx2 (Mus musculus) | 6480464 | triptonide results in increased expression of HMX2 mRNA | CTD | PMID:33045310 | HMX2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of HMX2 mRNA | CTD | PMID:24383497 | HMX2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of HMX2 gene | CTD | PMID:29154799 | HMX2 | Human | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMX2 mRNA | CTD | PMID:27188386 | |